Phoolish.org Directory: A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z



Wednesday, April 4, 2007

Health Tip: If You Have Rheumatoid Arthritis

Nude Photo

(HealthDay News) -- Rheumatoid arthritis is a chronic disease that primarily affects the joints.

Pain may start in any joint, but occurs most often in the fingers, hands and wrists, the Arthritis Foundation says. Other symptoms may include stiffness, flu-like aches, fever, and muscle pain.

In RA, pain often is symmetrical, meaning that if it hurts on the left hand, the same joint will hurt on the right one.

Drugs called NSAIDs are frequently prescribed to reduce joint inflammation. Other medicines may be prescribed specifically for pain.

The foundation recommends seeing a doctor as soon as symptoms flare, to miminize joint deterioriation and pain.

Good Communication Key to Rheumatoid Arthritis Care

Nude Photo

FRIDAY, May 26 (HealthDay News) -- Doctors skilled in communicating with patients do much better when it comes to treating the rheumatic diseases, a new study finds.

Researchers at Baylor College of Medicine, in Houston, say patient-centered communication helps build trust between doctor and patient -- a key factor in promoting improved quality of life, compliance with treatment, and better health outcomes.

In the study, the Texas team assessed 102 black, Hispanic and white patients with rheumatoid arthritis or systemic lupus erythematosus (SLE). The patients filled out a questionnaire that asked about various aspects of their medical encounters, including doctors' ability to transmit information, sensitivity to concerns, reassurance and support, and patient-centered behavior (e.g. "My doctors always ask me what I need").

The researchers also evaluated the patients' willingness to disclose information to their doctors and their trust in the health-care system.

The team found that a patient's trust in their doctor was independently associated with ethnicity, quality of the patient-doctor relationship, disease activity, and trust in the health-care system. Hispanic and black patients tended to have a lower level of trust in the health-care system compared to white patients.

Patient-centered communication by doctors was the only variable that was significantly associated with patients' willingness to disclose important information to their doctor. There was no association between trust or ethnicity and patient disclosure of information.

"The finding suggests that physician interaction styles that are centered on patients' concerns result in more effective communication on the part of the patient, clearly reinforcing the importance of the doctor-patient dynamic," the study authors wrote.

Emphasizing these components of the patient-doctor relationship can lead to increased information sharing by patients, they concluded.

The study appears in the June issue of Arthritis Care & Research.

Cancer Drug Gleevec May Ease Rheumatoid Arthritis

Nude Photo

THURSDAY, Sept. 14 (HealthDay News) -- The cancer "wonder" drug Gleevec, used to beat back leukemia and certain types of stomach tumors, also shows promise against autoimmune diseases such as rheumatoid arthritis.

"The data are very impressive, as impressive as anything I've ever studied," said study researcher and Stanford University rheumatologist Dr. William H. Robinson.

His team's findings were published online Sept. 14 in advance of their publication in the October print issue of the Journal of Clinical Investigation.

Robinson's group was screening drugs that might possibly help the estimated 50 percent of rheumatoid arthritis patients who do not adequately respond to current therapies.

Intrigued by case reports showing that rheumatoid arthritis symptoms improved in patients who received Gleevec (imatinib) as part of their cancer treatment, the researchers decided to test the drug in a mouse model of rheumatoid arthritis. These mice developed a disease similar to rheumatoid arthritis called collagen-induced arthritis.

Gleevec almost completely prevented the development of collagen-induced arthritis in healthy mice, Robinson's team reported. Compared to results in untreated mice, the drug also stopped disease progression and significantly reduced levels of bone destruction, inflammation, and tumor-like growth in and around the linings of joints.

The researchers also tested Gleevec on cells taken from the joints of humans with rheumatoid arthritis. They found that the drug shut down the cells' production of tumor necrosis factor-alpha (TNFa), a messenger molecule that drives rheumatoid arthritis-associated inflammation.

Gleevec also halted the proliferation of fibroblasts, the cells that cause tumor-like growth in joint linings.

"Gleevec inhibits several types of cells that are critical in rheumatoid arthritis," Robinson said. "But these cells are also critical in other diseases such as scleroderma, psoriasis and inflammatory bowel disease. Our results suggest a need for clinical trials of Gleevec in several human autoimmune diseases to see if it provides a benefit."

Although Gleevec is used in chemotherapy regimens, it's technically not a chemotherapy pill. It was designed to target gene mutations associated with chronic myelogenous leukemia (CLL) and certain types of stomach cancers, for which it has proven very effective.

"Overall, it's very well-tolerated," Robinson added. "Although there are some side effects such as bone-marrow suppression, it's not like conventional chemotherapy that causes hair loss and the sloughing of intestinal linings."

Rheumatoid arthritis is a chronic disease characterized by inflammation of the lining of the joints. It can lead to joint damage, resulting in pain, loss of function and disability, according to the Arthritis Foundation.

Because many rheumatoid arthritis drugs are administered by injection, Robinson said there's also been a "tremendous need" for therapeutic options in pill form. His research suggests that doses of Gleevec lower than those used in cancer treatment would benefit patients with autoimmune disease while causing fewer side effects.

Two case reports -- one involving a leukemia patient and another involving a patient with stomach cancer -- showed that treatment with Gleevec led to dramatic improvements in their rheumatoid arthritis symptoms, Robinson said.

And in an open-label trial of Gleevec, two rheumatoid-arthritis patients showed significant improvement, while a third patient showed only mild improvement, he said.

Because patients in open-label trials know they're receiving an experimental treatment, the results aren't conclusive because improvements may be related to a placebo effect. "You can't draw conclusions about whether or not something will work in human disease without a multi-center, placebo-controlled randomized, double-blinded trial," Robinson said.

Dr. Jonathan Edwards, a professor of connective tissue medicine at University College London, in England, doesn't share Robinson's enthusiasm for Gleevec as a possible treatment for rheumatoid arthritis. He also questioned the study's methodology.

"If we want to know whether or not Gleevec is helpful for rheumatoid arthritis, then the proper scientific approach is to ask the question directly," Edwards said. "You see if people with rheumatoid arthritis get better when given Gleevec."

"Giving Gleevec to mice that have been subjected experimentally to a form of arthritis which looks a bit like rheumatoid arthritis but has a completely different mechanism, is both irrelevant and in my view hard to justify ethically," Edwards added.

Robinson acknowleded that collagen-induced arthritis is not a precise reflection of human disease. "Generally, the mechanisms are similar, but it's far from a perfect model," he said.

Still, he remains hopeful that any forthcoming clinical trial will confirm that Gleevec is as effective in treating arthritic humans as it was in helping arthritic mice.

"It's an exciting time in autoimmunity, because we've had seven-plus drug approvals for rheumatoid arthritis in the past five to 10 years, and it's really changed clinical practice," he said.

"Hopefully, drugs such as Gleevec will take us to the next level where maybe we can treat the disease in people who currently don't adequately respond to other therapies," Robinson said.

SOURCES: William H. Robinson, M.D., Ph.D., Stanford University, Stanford, Calif.; Jonathan Edwards, M.D., professor, Connective Tissue Medicine, University College London, England; Sept. 14, 2006, early online edition, Journal of Clinical Investigation

Research Yields Clues to Lupus, Rheumatoid Arthritis

Nude Photo

THURSDAY, Aug. 31 (HealthDay News) -- Scientists say they've spotted potential new cellular targets for treating lupus, rheumatoid arthritis and other autoimmune disorders.

In research with mice, Japanese scientists found that blood platelet function plays an important role in an autoimmune kidney disease called crescentic glomerulonenephritis.

Their study, published in the September issue of the journal Arthritis & Rheumatism, also sheds light on the involvement of BLOC-1, which controls lysosomes, tiny organelles that contain digestive enzymes needed to maintain healthy cells function.

"The profound role of BLOC-1 appears to be platelet-specific among immuno-inflammatory cell types. BLOC-1 is a possible therapeutic target for suppression of platelet functions without compromising physiologic immune responses," said researchers at Tohoku University Graduate School of Medicine.

In another study, Finnish scientists identified a new type of adhesion molecule (amine oxidase, copper containing 3 - AOC3) that's highly expressed on vessels of inflamed human joint tissue.

AOC3, also called vascular adhesion protein 1, spurs inflammation by interfering with the infiltration of leukocytes (white blood cells) into rheumatoid joints, the study authors said.

-- Robert Preidt

Biggest Specialty Drug Spending Increase Found With Anti-Inflammatories

Nude Photo

WEDNESDAY, June 7 (HealthDay News) -- Americans spent 33.9 percent more in 2005 on anti-inflammatories -- the biggest percentage increase in any specialty drug category, a new U.S. report finds.

Drugs used to treat autoimmune diseases -- such as rheumatoid arthritis -- include the injectable brands Enbrel, Humira, Kineret and Remicade . These drugs have an average cost of $1,417 per prescription and comprise more than 19 percent of the yearly total that most patients are allowed to spend on a specialty drug in a drug benefit plan.

The biggest reason for this dramatic increase in spending for these drugs? According to the 2006 Express Scripts Specialty Drug Trend Report, treatments for inflammatory diseases such as rheumatoid arthritis are beginning earlier in a patient's life and lasting longer. Additional uses for medications -- such as Enbrel being used to treat psoriasis -- are also causing more patients to use these drugs.

Costs seem to be somewhat controlled with a reported increase in specialty pharmacy usage -- up 77 percent in 2005. Home prescription deliveries decreased by 30 percent, while local pharmacy pickups decreased by 2 percent.

"Enhanced patient-care models and management programs offered by specialty pharmacies encourage therapy adherence, helping to improve outcomes while reducing overall treatment costs," Dr. Steve Miller, chief medical officer of Express Script's CuraScript, said in a prepared statement.

Other statistics noted in the report:

* After anti-inflammatories, the class of drugs used to treat multiple sclerosis experienced the next largest increase, at 11.7 percent per prescription.
* Inflation pushed anti-cancer drugs to an average of almost $1,600 per prescription, and drugs for treating anemia saw a 6 percent increase in spending.
* Technology advancements in tests and screenings drove the use of growth hormone replacement drugs to increase by 10 percent.
* Anticoagulant usage increased 21.4 percent -- but future generic alternatives to some expensive brands in this category could help curtail these costs.
* Reduced utilization caused a decrease in spending for infertility drugs by 3.9 percent, and specialty antiviral drugs saw a decrease of 6.7 percent.

-- Diana Kohnle

Anemone, Shrub Compounds Battle Rheumatoid Arthritis

Nude Photo

THURSDAY, Nov. 9 (HealthDay News) -- Natural compounds from a sea anemone extract and from the rue shrub plant block autoimmune disease responses in both type 1 diabetes and rheumatoid arthritis, U.S. researchers report.

Scientists at the University of California, Irvine, conducted tests on rats and on blood samples from people with type 1 diabetes and on joint fluid from rheumatoid arthritis patients. They found that these compounds worked to deter the effects of destructive T-cells.

Both SL5 (from the sea anemone) and PAP-1 (from the rue shrub) block an ion channel in the T-cells, which prevents these cells from proliferating and producing chemicals called cytokines. These cytokines can attack healthy cells in people with autoimmune diseases.

The findings were published this week in the early online edition of the journal Proceedings of the National Academy of Sciences.

The researchers say it may be possible to use the compounds to develop new autoimmune disease treatments that target the destructive T-cells but still allow other white blood cells to fight disease and infection in the body.

"Autoimmune diseases affect millions of Americans, and any new therapies that can aid them will have great significance," researcher George Chandy of the university's School of Medicine, said in a prepared statement.

"What's promising about this study is that we identified a protein target on the T-cells that promotes autoimmune activity and the compounds that can selectively block the target and shut down the destructive cells," Chandy said.

He and his colleagues are currently conducting preclinical safety studies on PAP-1 and SL5 in collaboration with AIRMID, a San Francisco-area biotech company.

-- Robert Preidt

Acupuncture, Turmeric May Help Ease Arthritis

Nude Photo

MONDAY, Oct. 30 (HealthDay News) -- Acupuncture and an extract of turmeric -- the spice that gives curry its kick -- may both offer significant pain relief to some arthritis patients, two new studies suggest.

Reporting in the November issue of Arthritis & Rheumatism, a German team says a combination of acupuncture and conventional medicine can boost quality of life for patients suffering from osteoarthritis.

And in a second study in the same issue, American researchers say the ingestion of a special turmeric extract could help prevent or curb both acute and chronic rheumatoid arthritis.

The findings should be heartening to the roughly 40 percent of arthritis patients in the United States who say they've turned to some form of alternative medicine.

"If I had arthritis, I would be very excited about this," said Dr. Janet L. Funk, the lead author of the turmeric study and an assistant professor of physiological sciences at the University of Arizona in Tucson.

According to the Arthritis Foundation, nearly one in five Americans (46 million) suffers from one of the more than 100 various joint diseases that constitute arthritis. An additional 23 million have chronic joint pain that has yet to be formally diagnosed.

Osteoarthritis is caused by a progressive degeneration of bone cartilage and is the most common type of arthritis in the United States. Rheumatoid arthritis is an immunological disorder characterized by a painful inflammation of the lining of the joints.

In her study, Funk built on earlier research she had conducted with rats. Those efforts suggested that turmeric might prevent joint inflammation.

In her current work, she first broke down the specific contents of commonly sold turmeric dietary supplements.

In the lab, she and her colleagues then isolated a turmeric extract that was free of essential oils and structurally similar to that found in commercial varieties. The extract was based largely on curcuminoids -- a compound they believed to be most protective against arthritic inflammation.

Funk's group administered the extract to female rats both before and after the onset of rheumatoid arthritis. They then tracked changes in the rodents' bone density and integrity.

The turmeric extract appeared to block inflammatory pathways associated with rheumatoid arthritis in rats at a particularly early point in the development of the disease. The extract had a beneficial impact if given three days after arthritis set in, but not if given eight days after disease onset.

Investigations in the laboratory revealed that turmeric stops a particular protein from launching an inflammatory "chain reaction" linked to swelling and pain. The expression of hundreds of genes normally involved in instigating bone destruction and swelling was also altered by the turmeric.

Funk stressed, however, that the findings are preliminary, and the extract needs to be tested in people.

"I feel an obligation to make clear that people should not run out to buy and consume turmeric powder," she cautioned. "First of all, a very small percent of the ground-up root that we buy in the grocery store is the protective part of the root, so it's not going to get you anywhere." In fact, the compound used in the study probably makes up only about 3 percent of the weight of current store-bought turmeric supplements, Funk said.

"That means that if this pans out in further studies, patients will be taking a purified extract, and this is all really exciting," she said. "But we still need conclusive proof that this extract is safe and efficacious."

In the second study, researchers led by Dr. Claudia M. Witt of Charite University Medical Center in Berlin spent three years tracking the treatment results of 3,500 male and female osteoarthritis patients suffering from either knee or hip pain.

For six months, all the participants were permitted to continue whatever conventional western medical treatments they had been undergoing prior to the onset of the treatment trials.

However, in addition, over 3,200 of the patients also received up to 15 sessions of needle-stimulation acupuncture during the first three months of the study. The remaining 310 patients received no acupuncture in the first three months. They were offered such treatment in the final three months of the study period, however.

All acupuncture sessions were administered by physicians who had received a minimum of 140 hours of certified training.

Symptom and pain questionnaires were completed at the onset of the study and at three months and six months of therapy.

Patients with chronic osteoarthritis pain who underwent a combination of routine medical care plus acupuncture demonstrated significant quality of life improvements, the researchers found. This included increased mobility and pain reduction above and beyond that experienced by patients who did not receive acupuncture.

For those who began their acupuncture treatments immediately, osteoarthritis improvement held steady three months after cessation of the sessions. For those patients who had begun acupuncture three months into the study period, comparable improvements occurred by the time they ended their sessions at the six-month mark.

The authors said acupuncture appeared to be a safe medical intervention with minor side effects observed in just over 5 percent of patients.

The study, one of the largest of its kind, demonstrated that acupuncture was a viable therapeutic option for people suffering from osteoarthritis, the German team said.

"I'm not surprised that people can be treated with acupuncture and get better," said Marshall H. Sager, a Bala Cynwyd, Pa.-based doctor of osteopathic medicine, acupuncturist, and past president of the American Academy of Medical Acupuncture.

"Using acupuncture adjunctively with western medicine is very common, because if you can do both approaches, you're way ahead of the game," he said. "Some people are not amenable to medication, either because of allergenic effects or because they just don't want to consume artificial things. And so, this is a way to start the healing process by engaging and stimulating the body's own inherent ability to heal itself."

However, Sager cautioned that American patients who consider this alternative route should choose carefully when they seek out acupuncture care.

" 'Medical acupuncture' is acupuncture as practiced by a physician, which is much different than acupuncture as practiced by non-physicians in the east, such as in China," he noted. "And I would most definitely recommend that patients in the west deal with a physician that's properly trained and a member of the American Academy of Medical Acupuncture," Sager said.

SOURCES: Janet L. Funk, M.D., assistant professor, physiological sciences, department of medicine, University of Arizona, Tucson; Marshall H. Sager, D.O., past president, American Academy of Medical Acupuncture, and acupuncturist, Bala Cynwyd, Pa.; November 2006, Arthritis & Rheumatism

Alcohol May Slow Rheumatoid Arthritis

Nude Photo

MONDAY, Dec. 18 (HealthDay News) -- A copious dose of alcohol reduced the risk that mice would develop rheumatoid arthritis, Swedish researchers report.

That doesn't mean humans should turn to the bottle to stave off the painful joint disease, however.

Asked if he would attempt a similar experiment in humans, lead researcher Dr. Andrzej Tarkowski, professor of rheumatology at Goteborg University said, "I wouldn't dare to do it."

The mice were given a daily regimen of tap water supplemented with 10 percent alcohol. "That would do liver damage in humans," Tarkowski noted.

"There may be some kind of human correlate, but that's not what I'm studying," added Tarkowski, who published the findings in this week's Proceedings of the National Academy of Sciences.

Instead, Tarkowski is interested in the mechanism by which alcohol might help prevent rheumatoid arthritis, an autoimmune condition in which the body attacks its own joint tissue.

"We have shown that it goes through the up-regulation [increase] of testosterone," he said. "That down-regulates inflammation, which is part of the arthritic process."

Test tube studies also show that alcohol increases the migration of white blood cells, which take part in the inflammatory process, Tarkowski.

In the experiment, male mice were given injections of collagen to induce rheumatoid arthritis. The researchers noted a significantly lower onset of disease and fewer destructive symptoms in mice who drank water with 10 percent alcohol added in, than in those who drank plain tap water.

Dr Stephen Lindsey, head of rheumatology at the Ochsner Clinic Foundation Hospital in Baton Rouge, La., agreed that the study findings aren't a license to start drinking.

"This paper is germane to male mice," Lindsey said. "That's all we can say at this time." Another reason for caution is that many of the medications used to treat rheumatoid arthritis are also toxic to the liver, as is alcohol, he said. This study also focused on male mice and testosterone, when most rheumatoid arthritis sufferers are female.

Finally, Lindsey said, the study dealt with prevention of arthritis, not its treatment.

The findings do suggest directions for possible trials, he said, perhaps among men with rheumatoid arthritis to see if their condition is affected by alcohol consumption.

However, there is no reason to change the standing recommendations for people with arthritis, he noted.

"The standard advice is to do everything in moderation, other than smoking," Lindsey said. "A couple of cups of coffee a day, one or two drinks a day, but no smoking."

Tarkowski saw some possibility in using acetaldehyde, a breakdown product of alcohol, in prevention of rheumatoid arthritis. However, Lindsey again cautioned that acetaldehyde "would have to be used in relatively small amounts because, in large amounts, it is toxic."

SOURCES: Andrzej Tarkowski, M.D., professor, rheumatology, Goteborg University, Sweden; Stephen Lindsey, M.D., head of rheumatology, Ochsner Clinic Foundation Hospital, Baton Rouge, La; Dec. 18-22, 2006, Proceedings of the National Academy of Sciences

Model May Predict Rheumatoid Arthritis

Nude Photo

New Assessment Could Identify Which Arthritis Patients Need Aggressive Treatment

Jan. 30, 2007 -- A new prediction model developed in the Netherlands may make it easier for doctors to identify which arthritis patients need early, aggressive treatment and which do not.

It is now clear that the best strategy for preventing potentially crippling joint damage in patients with rheumatoid arthritis is very early, aggressive treatment with a potentially toxic combination of drugs.

But not all patients with arthritis have the progressive form of the disease.

Studies suggest that pain and stiffness symptoms resolve on their own in time in as many as half of newly diagnosed patients with undifferentiated arthritis. Undifferentiated arthritis is arthritis that doesn't meet criteria for a more specific type.

But about a third of undifferentiated arthritis patients end up with a diagnosis of rheumatoid arthritis, an autoimmune disease that affects joints and other parts of the body.

In an effort to help guide treatment decisions, researchers in the Netherlands have developed a model for predicting a patient's rheumatoid arthritis risk. The research is published in the February issue of Arthritis and Rheumatism.

"This model would be very easy to adapt to clinical practice, because it is based on assessments rheumatologists already make," researcher Annette van der Helm-van Mil, MD, PhD, tells WebMD.

Model Identified Rheumatoid Arthritis Early

The model was developed using data from 570 newly diagnosed patients with undifferentiated arthritis who were followed for a year.

During that time, 177 were diagnosed with rheumatoid arthritis, while the remaining 393 either achieved remission, did not progress, or were diagnosed with other rheumatologic diseases.

Using a combination of questionnaires, physical examinations, and blood samples, van der Helm-van Mil and her colleagues from the Leiden University Medical Center developed their nine-point model.

Rheumatoid Arthritis Danger Signs

Important predictive variables included a patient's age, sex (most rheumatoid arthritis patients are women), number of tender joints and swollen joints, and certain symptoms characteristic of rheumatoid arthritis -- such as morning stiffness and location of affected joints.

Other tests, including blood tests for C-reactive protein level and rheumatoid factor, were also included in the model.

Based on the assessments, the researchers came up with a 14-point predictive score, with 0 being the lowest likelihood of progression to rheumatoid arthritis and 14 representing the highest likelihood.

None of the study's patients with a score of 3 or less ended up with a diagnosis of rheumatoid arthritis; all of those with a score of 11 or greater did.

The likelihood of progression to rheumatoid arthritis increased in tandem with the scores for those between 4 and 10.

Van der Helm-van Mil says the findings must be confirmed in other patient populations. But she says she's confident the model can be useful in hospitals and doctor's offices.

"This model has very good predictive ability," she says. "It is very sensitive."

Clinical Value Uncertain

Dallas rheumatologist Scott J. Zashin, MD, tells WebMD the model may prove to be a useful tool for predicting rheumatoid arthritis.

One major unanswered question, he adds, is whether its use will lead to different treatment decisions. "I'm not sure that it will, but it would be worthwhile to find out."

Zashin is a clinical assistant professor at the University of Texas Southwestern Medical Center in Dallas.

"For years we have been using our own clinical judgments, based on the measurements used in this model, to make decisions about treatment," says Zashin.

"Formalizing these measurements may help us better identify the patients who will benefit from early treatment, but I think that remains to be seen," he says.

SOURCES: van der Helm-van Mil, A. Arthritis and Rheumatism, February 2007; vol 56: pp 433-440. Annette H.M. van der Helm-van Mil, MD, PhD, Leiden University Medical Center, Leiden, Netherlands. Scott J. Zashin, MD, rheumatologist; clinical assistant professor, University of Texas Southwestern Medical Center, Dallas.

New Score Helps Spot Rheumatoid Arthritis Sufferers

Nude Photo

TUESDAY, Jan. 30 (HealthDay News) -- Dutch researchers may have a new method of predicting whether patients with arthritic symptoms will progress to the autoimmune form of the disease, rheumatoid arthritis.

By differentiating those patients who will develop full-blown rheumatoid arthritis from those who will not, the new formula could speed earlier treatment of rheumatoid arthritis patients, reducing damage to their joints while sparing those who will not develop the disease the side effects sometimes associated with rheumatoid arthritis drugs.

"You don't want to give treatment to patients who will spontaneously remit, because they will not get the benefit," explained lead researcher Dr. Annette van der Helm-van Mil, a rheumatologist at Leiden University Medical Center in the Netherlands. "You want to give it only to the patients who have a high chance of progressing to rheumatoid arthritis."

The findings are published in the February issue of Arthritis & Rheumatism.

According to the Arthritis Foundation, rheumatoid arthritis is an autoimmune disease that affects some 2.1 million Americans, most of them women. The disease often presents first as "undifferentiated arthritis," a condition that lacks the criteria for a more definitive diagnosis. Up to 50 percent of patients with undifferentiated arthritis will spontaneously go into remission, while another third will progress to rheumatoid arthritis.

The problem, said van der Helm-van Mil, is that treatment of rheumatoid arthritis with the rug methotrexate at this point can reduce future joint damage but is also potentially toxic. That's why spotting patients with true rheumatoid arthritis early is so important.

In their study, the Dutch group studied a cohort of 570 patients who presented to the Leiden Early Arthritis Clinic with undifferentiated arthritis, 177 of whom progressed to rheumatoid arthritis within one year.

They identified nine variables, including gender, age, the number and distribution of stiff and swollen joints, and three laboratory tests. When factored into an algorithm, these factors could predict the likelihood of developing rheumatoid arthritis with nearly 90 percent accuracy.

Scores from this "prediction rule" ranged from zero to 14. Patients who score six or below have a 91 percent chance of not developing rheumatoid arthritis, the researchers said, while those who score above 8 have an 84 percent chance of progressing to the autoimmune disease. Those who score seven (about 25 percent of patients) have a 50/50 chance of developing rheumatoid arthritis, while those who score above 10 have a 100 percent chance of developing the disease.

"Using information like this can be extremely helpful in managing patients," said Dr. Clifton Bingham III, assistant professor of medicine in the divisions of rheumatology and allergy and clinical immunology at the Johns Hopkins Arthritis Center in Baltimore, Md. "One of the large questions we face in patients who present with undifferentiated arthritis is knowing which of those patients should receive more aggressive therapy to minimize the long-term consequences of the disease or to decrease the likelihood of going on to develop rheumatoid arthritis," he explained.

Bingham noted, however, that this information may be more useful in the United States for primary care physicians than for rheumatologists. The formula already reflects common practice among rheumatologists, he said. Plus, health care differences between the Netherlands and the United States mean that rheumatologists in the U.S. may be less likely to see patients with undifferentiated arthritis than their counterparts in Leiden, because in the U.S., these patients are more likely to present to primary care doctors first. By the time the patient gets to a rheumatologist, he or she has often already developed more-definite rheumatoid arthritis, Bingham said.

"So, it provides a decision tool for primary care doctors to use in determining which patients are most appropriate for early referral to a rheumatologist," he said.

Bingham cautioned that several caveats must be considered before implementing this prediction score in the United States. First, it needs to be validated in other locales and with other patient populations. Second, he cautioned against using this test to produce strict cutoff values for treatment, since what might be true in a population isn't always true for an individual patient. Finally, he noted that the study doesn't address which treatment regimen is most effective once a patient actually develops rheumatoid arthritis.

"We face that question [of treatment] perhaps more often than the question being raised in this study," Bingham said. "We don't yet know how to answer that question."

The methods used in this study could possibly be used to help solve that puzzle, he added.

SOURCES: Annette van der Helm-van Mil, M.D. Ph.D., rheumatologist, Leiden University Medical Center, Leiden, the Netherlands; Clifton Bingham III, M.D., assistant professor, medicine, division of rheumatology and allergy, Johns Hopkins University, Baltimore, Md.; February 2007, Arthritis & Rheumatism

Protein May Be Key to Rheumatoid Arthritis

Nude Photo

WEDNESDAY, March 28 (HealthDay News) -- In the quest for the causes of and potential treatments for rheumatoid arthritis, Japanese researchers have identified a protein that could be a target for future therapy.

Rheumatoid arthritis (RA) is a chronic and disabling autoimmune disease that first attacks the fluid that surrounds the joints, causing it to thicken and grow abnormally, damaging the joints and surrounding cartilage rather than protecting them. More than 2 million Americans suffer from the illness, according to the Arthritis Foundation.

By identifying a protein that appears to be one of the culprits in the unhealthy buildup of this fluid, which is called synovial fluid, Dr. Yasushi Miura and her colleagues at Kobe University School of Medicine hope that a new, targeted medication can be developed to treat the disease.

"The protein Decoy receptor 3 (DcR3) is one of the pathological factors of RA and can be a new therapeutic target for treatment," said Miura, an associate professor in the division of orthopedic sciences at the medical school.

Her findings are in the April issue of Arthritis & Rheumatism, the journal of the American College of Rheumatology.

DcR3 is a member of the large tumor necrosis factor receptor (TNFR) "super family," which has been identified in the last decade as important in the regulation of cell growth and cell death, fundamental processes in biology, said Dr. Robert Hoffman, director of the division of rheumatology and immunology at the University of Miami Miller School of Medicine in Florida.

"We have known of the importance of cell growth and cell death in studying cancer but more recently have found that it is also important in autoimmune diseases like RA and lupus," he said.

It was the similarity between the growth of malignant tumors and the abnormal growth of synovial tissue, called hyperplasia, that sparked Miura's research into DcR3 and rheumatoid arthritis. DcR3 is known to be produced in tumor cells, including lung and colon cancers.

What Miura and her colleagues found was that DcR3 works with another member of the TNFR family to slow the normal cell death of synovial fluid cells, resulting in the hyperplasia that causes some of the inflammation characteristic of rheumatoid arthritis.

Hoffman said: "This is a novel application of the connection between this specific member of the TNFR super family and RA, and studies like this are how we advance science. But it is currently a giant leap to suggest that this could be a therapy for RA."

For their study, Miura and her colleagues isolated and cultured synovial fluid from19 patients with rheumatoid arthritis, obtained during total knee replacement surgery. For comparison, they also extracted synovial fluid in the same manner from 14 patients with osteoarthritis.

The researchers then exposed the synovial fluid to another TNFR protein called Fas, which induces cell death, called apoptosis. Finally, the fluid was incubated with a pro-inflammatory member of the TNFR family, called TNFa. The TNFR family includes proteins that both induce and retard cell death, Miura explained.

While DcR3 was present in the same amounts in the fluids of both the rheumatoid arthritis and osteoarthritis patients, when the TNFa was introduced, DcR3 production increased in the fluid of the RA patients, slowing down the Fas-induced cell death. The rate of cell death did not change in the fluid of the osteoarthritis patients, perhaps, Miura suggested, because the TNFa levels were higher in the fluid of RA patients to begin with.

Miura said the results show that DcR3 acts in conjunction with TNFa to suppress the cell death necessary to keep synovial fluid healthy, and research aimed at reducing the amount of DcR3 in the synovial fluid in rheumatoid arthritis patients could be productive.

Dr. Stephen Lindsey, head of rheumatology at the Ochsner Clinic Foundation in Baton Rouge, La., said, "We are always looking for better and more specific targets to control immune response, and this study is very intriguing."

Lindsey said there are drugs available that inhibit those proteins that suppress cell death, but because they are "global," rather than targeted to particular proteins, there are many side affects, including infection.

SOURCES: Yasushi Miura, M.D., Ph.D., Kobe University School of Medicine, Kobe, Japan; Stephen Lindsey, M.D., head of rheumatology, Ochsner Clinic Foundation, Baton Rouge, La.; Robert Hoffman, M.D., professor of medicine, microbiology and immunology, director of the division of rheumatology and immunology, University of Miami Miller School of Medicine, Florida; April 2007, Arthritis & Rheumatism

Rheumatologist...The Arthritis Buster

Nude Photo

Who is a rheumatologist?

A rheumatologist is a medical doctor who specializes in the non-surgical treatment of rheumatic illnesses, especially arthritis.

Rheumatologists have special interests in unexplained rash, fever, arthritis, anemia, weakness, weight loss, fatigue, joint or muscle pain, autoimmune disease, and anorexia. They often serve as consultants, acting like detectives for other doctors.

Rheumatologists have particular skills in the evaluation of the over 100 forms of arthritis, and have special interest in rheumatoid arthritis, spondylitis, psoriatic arthritis, systemic lupus erythematosus, antiphospholipid syndrome, Still disease, dermatomyositis, Sjogren's syndrome, vasculitis, scleroderma, mixed connective tissue disease, sarcoidosis, Lyme disease, osteomyelitis, osteoarthritis, back pain, gout, pseudogout, relapsing polychondritis, Henoch- Schonlein purpura, serum sickness, reactive arthritis, Kawasaki disease, fibromyalgia, erythromelalgia, Raynaud's disease, growing pains, iritis, osteoporosis, reflex sympathetic dystrophy, and others.

Classical adult rheumatology training includes four years of medical school, one year of internship in internal medicine, two years of internal medicine residency, and two years of rheumatology fellowship. There is a subspecialty board for rheumatology certification, offered by the American Board of Internal Medicine, which can provide board certification to approved rheumatologists.

Pediatric rheumatologists are physicians who specialize in providing comprehensive care to children (as well as their families) with rheumatic diseases, especially arthritis.

Pediatric rheumatologists are pediatricians who have completed an additional 2-3 years of specialized training in pediatric rheumatology and are usually board-certified in pediatric rheumatology.

Kathleen Turner Raises Her Voice About Rheumatoid Arthritis

Nude Photo

Years of Silent Suffering Inspires Powerful Message in Support of Early Diagnosis and Treatment

February 2002 (Newstream) -- Award-winning actress Kathleen Turner is spearheading a new educational campaign to raise awareness about rheumatoid arthritis, otherwise known as RA, a disease she has waged a personal battle with for over 10 years. Because of her personal and frustrating struggle with RA, Turner wants to help others avoid the debilitating joint damage and disfigurement that can occur if it is not detected early and treated aggressively. Nearly 2.1 million Americans have RA, which can be difficult to diagnose because it can begin gradually with subtle, often inconsistent symptoms including painful swollen joints, fatigue and prolonged morning stiffness. Like most autoimmune diseases, the average time from onset until diagnosis of RA is three to five years.

Known for her energetic and seductive roles on stage and screen, Kathleen Turner hasn't let RA impede her career, despite the sometimes severe pain and joint stiffness. Now, she wants others to know that RA does not have to mean a lifetime of limitations.

"The year before I was diagnosed was terribly frightening. I didn't know what was happening to me. I didn't know why there was so much pain, and why I felt so ill, " said Kathleen Turner. "I'm involved in this campaign because I want people to know that they can get information, to know that they can manage this disease, and they can fight for their lives and their lifestyle. I want them to know that there is help."

Today, Kathleen Turner feels in control of her RA because she has educated herself about the disease and has gotten the help of a breakthrough biotech medicine. She is encouraging people with RA or with RA symptoms to act fast and empower themselves with information about the disease.

"Early diagnosis and treatment in patients with rheumatoid arthritis is critical," said Dr. Stephen Paget, Physician in Chief and Chairman of the Division of Rheumatology, Hospital for Special Surgery. "When inflammation starts, it starts within the first several months of the disease and destroys cartilage and joints. Providing patients with treatments that can inhibit the progression of the joint disease may help them lead more normal lives."

RA predominantly affects women in the prime of their lives who often are starting families, building careers and living an active lifestyle. Although RA is a progressive and potentially debilitating disease, the progression of the joint damage may be stopped if signs and symptoms are recognized and the disease is treated in its early stages.

In rheumatoid arthritis, unlike osteoarthritis, the body's immune system mistakenly attacks its joints and soft tissues. New therapies, such as biologic response modifiers have been shown not only to reduce pain and inflammation, but also to actually inhibit the progression of the joint disease.

The early warning signs of RA may include fatigue, prolonged morning stiffness, and difficulty in moving joints, and/or pain and inflammation in or around joints. If you think you, a friend or a family member may have RA, you should see a rheumatologist who can talk to you about the condition as well as early, aggressive therapy.

Insight Into Rheumatoid Arthritis

Nude Photo

Rheumatoid arthritis is not a modern disease. According to the Arthritis Foundation, American Indians living about 3,000 BC in what is now Tennessee showed signs of rheumatoid arthritis (RA).

As cited in Arthritis Today's (January/February 2000 issue,) the signs and symptoms of rheumatoid arthritis were first described in 1680 by the British physician Thomas Sydenham (who was sometimes called the English Hippocrates).

Rheumatoid arthritis is a chronic disease, characterized by periods of disease flares and remissions. Chronic inflammation of rheumatoid arthritis can cause permanent joint destruction and deformity. This form of arthritis is referred to as an autoimmune disease. Autoimmune diseases occur when the body tissues are mistakenly attacked by its own immune system. In automimmune diseases the antibodies in the blood and cells of the immune system target body tissues, where they can cause inflammation.

In rheumatoid arthritis, the tissue that is primary inflamed is the joint lining tissue called the synovial membrane. Normally, this tissue produces a small amount of joint fluid which lubricates and nourishes the cartilage of the joint. When it becomes inflamed, the synovial tissue produces an excessive amount of fluid filled with white blood cells that are potentially harmful to the cartilage. Furthermore, the inflamed synovial tissue becomes thickened and can wear away both cartilage and bone while loosening adjacent ligaments to cause deformity.



There is no known cure for rheumatoid arthritis. The treatment of rheumatoid arthritis optimally involves a combination of patient education, rest and exercise, joint protection, medications, and occasionally surgery.

Humira, Drug for Rheumatoid Arthritis

Nude Photo

Summary: The FDA has approved the drug Humira for the treatment of rheumatoid arthritis. Humira is a human antibody that blocks a protein known as tumor necrosis factor (TNF), which plays a key role in inflammation.

Comment: This is a big new drug for Abbott Laboratories, the maker of Humira. It joins Enbrel and Remicade as anti-TNF drugs.

FDA Approves New Therapy for Rheumatoid Arthritis

FDA has approved adalimumab (marketed by Abbott Laboratories as HUMIRA) to treat rheumatoid arthritis (RA). This is the second treatment of its kind and may significantly increase the availability of these therapeutics to patients.

HUMIRA is produced by recombinant DNA technology. It is a human-derived antibody that binds to human tumor necrosis factor alpha (TNF alpha). TNF is naturally produced by the body and is involved with normal inflammatory and immune responses. Individuals with rheumatoid arthritis, a disease that affects more than 2 million Americans, have high levels of TNF in the synovial fluid (lubricating fluid in joints). The extra TNF plays an important role in both the pathologic inflammation and the joint destruction that are hallmarks of RA.

By working against the inflammatory process, HUMIRA, like other TNF blockers has been shown to be effective in controlling symptoms of the disease. HUMIRA is indicated for reducing signs and symptoms and inhibiting the progression of structural damage in adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs). HUMIRA can be used alone or in combination with methotrexate or other DMARDs.

The efficacy and safety of HUMIRA were assessed in four randomized, double-blind studies in adult patients. HUMIRA was found to reduce signs and symptoms of rheumatoid arthritis in over half the patients. In one of the four studies, patients were treated for a year and then evaluated radiographically. Patients treated with HUMIRA plus methotrexate (MTX) demonstrated less joint deterioration than patients receiving MTX alone.

HUMIRA is administered as a single subcutaneous injection every other week. The package insert carries a bolded warning stating that serious, sometimes fatal, infections (including cases of tuberculosis and sepsis) have been reported with the use of TNF-blocking agents including HUMIRA. The most serious adverse events associated with HUMIRA are, as with other TNF blockers, serious infections, neurologic effects, and certain malignancies of the lymphoid system. A higher rate of lymphomas was observed than the expected rate in the general population, but RA patients, particularly those with active disease, may be at a higher risk for development of lymphoma. Patients with rheumatoid arthritis should discuss therapy options with their healthcare providers. HUMIRA is administered as a single subcutaneous injection every other week.

The FDA's Center for Biologics Evaluation and Research was able to approve this treatment ahead of deadline, reviewing the product within nine months (standard review is a ten-month cycle).

Bextra Gets New Warning On Label

Nude Photo

Bextra Label Updated with Boxed Warning Concerning Severe Skin Reactions and Warning Regarding Cardiovascular Risk

The Food and Drug Administration (FDA) announced today important new information on side effects associated with the use of Bextra, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID) which is indicated for the treatment of osteoarthritis, rheumatoid arthritis and dysmenorrhea (menstrual pain). A "boxed" warning, strengthening previous warnings about the risk of life-threatening skin reactions and a new bolded warning contraindicating the use of Bextra in patients undergoing coronary artery bypass graft (CABG) surgery will be added to the label.

In addition, the FDA will also seek input from the public and from outside experts on the appropriate uses for Bextra and other NSAIDs at a previously-announced Advisory Committee meeting, to be held early in 2005.

Boxed and bolded warnings provide healthcare professionals and patients with important information on drugs that may be associated with serious side effects in a way that maximizes the drug’s benefits and minimizes its risks.

Serious Skin Reactions The new boxed warning in the label states that patients taking Bextra have reported serious, potentially fatal skin reactions, including Steven-Johnson Syndrome and toxic epidermal necrolysis. These skin reactions are most likely to occur in the first 2 weeks of treatment, but can occur any time during therapy. In a few cases, these reactions have resulted in death. The labeling advises doctors that Bextra should be discontinued at the first appearance of a skin rash, mucosal lesions (such as sores on the inside of the mouth), or any other sign of allergic reactions. The new boxed warning also states that Bextra contains sulfa, and patients with a history of allergic reactions to sulfa may be at a greater risk of skin reactions.

As of November 2004, FDA had received reports of a total of 87 cases in the United States of severe skin reactions in association with Bextra, including Stevens-Johnson Syndrome and toxic epidermal necrolysis. Twenty of the 87 cases involved patients with a known allergy to sulfa. Of these 87 cases, 36 hospitalizations were reported, including 4 deaths. Other Cox-2 selective inhibitors and traditional NSAIDs such as naproxen and ibuprofen also have a risk for these rare, serious skin reactions, but the reported rate of these serious side effects appears to be greater for Bextra than for other COX-2 agents.

Cardiovascular Risks In addition to highlighting serious skin reactions, the strengthened label warnings also highlight new data about cardiovascular risks. A recently-completed study conducted by Pfizer, which included over 1,500 patients treated after CABG, showed an increased cardiovascular risk in patients treated with Bextra compared to placebo. Observed cardiovascular events included thromboembolic events such as myocardial infarction (heart attack), cerebrovascular accident (stroke), deep vein thrombosis (blood clots in the leg), and pulmonary embolism (blood clot in the lung).

Pfizer submitted the final report of the new CABG study to FDA on November 5, 2004. The report confirms the risk of the intravenous form (about 2 percent of patients had such an adverse event) and also shows that oral Bextra is associated with a lower, but some, risk (about 1 percent of patients) immediately following CABG surgery--a very specific medical setting. In the placebo group, about 0.5 percent of patients had an adverse cardiovascular event. Bextra is not approved for use in the treatment of postoperative pain of any type; however, FDA believes that these new findings should be made available to healthcare professionals and patients, and the bolded warning specifically contraindicates Bextra for treatment of pain immediately following CABG.

FDA urges health care providers and patients to report adverse event information to FDA via the MedWatch program by phone (1-800-FDA-1088), by fax (1-800-FDA-0178), or by the Internet http://www.fda.gov/medwatch/index.html . Reports can also be made directly to Pfizer, Inc., Peapack, N.J. at 1-800-323-4204.

Whether Weather Affects Arthritis

Nude Photo

Doctors who specialize in the treatment of patients with arthritis (myself included) generally agree that many patients experience a worsening of joint symptoms with changes in the weather. Moreover, folklore holds that the weather can affect arthritis as emphasized by sayings like "feeling under the weather." We know, for example, that weather clearly influences many health conditions. Examples of this relationship include altitude and ears popping, pollens in the air and asthma or sinus infection, sun rays and skin burning or skin cancer, cold weather and heart attacks, and gloomy, dark weather and depression. We also know that heat packs or hot showers can relax the muscles around the joints and relieve stiffness and pain for some. Conversely, ice packs can ease the inflammation in the joints themselves.

But does the weather actually affect arthritis? If so, how?

First, there hasn't been much real research science. In 1961, a famous arthritis specialist, J. Hollander M.D., conducted a study in which he built a climate chamber and demonstrated that high humidity combined with low barometric pressure were associated with increased joint pain and stiffness. Neither weather factor by itself seemed to influence joint symptoms. The study has been criticized because of the limited number of patients evaluated (12 patients). The theory of the study is that inflamed joints swell as the barometric pressure drops. This swelling irritates the nerves around the joints that sense pain and causes more stiffness.

Well, if this theory proved correct (and it is not universally accepted), should a person with arthritis move to a region with a dry climate?

The answer is no. Relocating to a different climatic environment does not seem to make a difference in the long run. Scientific studies have shown that no matter where people live their bodies seem to establish a new equilibrium to the local climate. As a result, changes in the weather affect the arthritis symptoms in the same manner regardless of the actual overall average weather. Moving is not likely to be beneficial long term. (To emphasize a point, I can tell you that there are plenty of busy rheumatologists in Arizona!)

What is the bottom line?

It appears that there is some evidence that the symptoms of certain persons with arthritis are influenced by CHANGES in the weather. This is not true for all people with arthritis, nor is it predictable what type of weather alterations will bother people. For example, in one room I may have a patient that complains that last week just before it rained, her joints began aching and now that it is warm, clear weather she feels better. Simultaneously, in the next room, a patient tells me that her joints are far worse today after it rained last week! What do I do with this information? Well, each patient must be evaluated (and evaluate themselves) uniquely. The bottom line is that while the exact cause(s) of the activation of arthritis symptoms may not yet be scientifically understood, each patient must make lifestyle and/or medication adjustments according to the particular weather conditions that they note influence their symptoms.

If a patient does experience joint pain and stiffness with weather changes, how harmful is this?

It is very important to appreciate that only joint SYMPTOMS (such as pain and stiffness) are influenced by weather. We do not have any evidence that weather changes lead to joint damage. Furthermore, weather changes have not been related to whether or not an individual develops arthritis.

Special Rheumatic Conditions

There are special rheumatic conditions that may be associated with arthritis and are clearly influenced by weather. In fact, as a rheumatologist, it is my job to inform patients with these conditions that they should do their best to avoid aggravating these conditions by limiting their exposure to certain weather situations. Here are some of these special conditions:

Muscle Cramps
The risk of muscle cramping increases when an exercise activity is pursued without an adequate warm-up. This is particularly true in environments that are cold. Therefore, it is very important to do warm-up stretches and get the muscles ready to work for you before you get in the game!

Systemic Lupus Erythematosus (Lupus)
Lupus is a potentially serious illness that can cause inflammation in a variety of internal organs, including the joints. Lupus can have a tendency to by activated by exposure to sunlight, a feature referred to as photosensitivity. Since ultraviolet light can trigger and worsen flare-ups of lupus that can involve the skin and/or the joints and other organs, patients with lupus should avoid sun exposure. Sunscreens and clothing that cover the extremities are essential.

Raynaud's Phenomenon
Raynaud's phenomenon can be associated with a number of conditions that feature arthritis, including scleroderma, rheumatoid arthritis, systemic lupus erythematosus, mixed connective tissue disease, polymyositis, and others. Raynaud's phenomenon is a condition that results in the discoloration of the fingers and/or the toes when the patient is exposed to changes in temperature (cold or hot) or emotional events. Skin discoloration occurs because an abnormal spasm of the blood vessels results in a diminished blood supply. Initially, the digit(s) involved turn white because of diminished blood supply. The digit(s) then turn blue because of prolonged lack of oxygen. Finally, the blood vessels reopen, causing a local "flushing" phenomenon, which turns the digit(s) red. This three-phase color sequence (white to blue to red), which occurs most often upon exposure to cold temperature, is characteristic of Raynaud's phenomenon. Persons with Raynaud's phenomenon should minimize their exposure to extremes of temperature (particularly cold) and rapid changes of temperature. These patients can often benefit by living in environments that are warmer. This may mean moving for patients with severe disease. To emphasize (and offer a potential financial pearl), it should be noted that the utility companies in many states offer discounts for persons with weather related conditions that require extra heating!

Rheumatoid Arthritis - When Do I Call The Doctor?

Nude Photo

Rheumatoid Warning Signs

Doctors pay for beepers. So what are these beepers for? This article is about a reason that my beeper battery commonly wears down. And, I am happy that it is being used for this purpose!

Persons with rheumatoid arthritis can develop certain symptoms that are really warning signs of something occurring in their bodies that is not what the doctor expects to happen. These are signs that can also sometimes represent a significant danger. These "rheumatoid warning signs" are reasons to call the doctor so that they can be interpreted in light of the patient's overall condition. When the doctor who is aware of your condition hears of these symptoms he/she can determine whether or not they are serious and if any action should be taken immediately or in the near future.

Rheumatoid warning signs can represent a worsening or complications of the rheumatoid disease, side effects of medications, or a new illness that is complicating the condition of patients with rheumatoid arthritis. Patients with rheumatoid arthritis should be aware of these rheumatoid warning signs so that they can contact their healthcare practitioner before their health is jeopardized.

Here are some warning signs that I like my patients to call me about:
Worsening of Joint Symptoms: This includes more pain, more swelling, additional joint involvement, redness, stiffness, or limitation of function. The doctor will determine whether or not these are significant, not the patient. Sometimes, patients have just begun a medication and some minor increase in joint problems might be occurring while the medication is taking effect. However, worsening symptoms can also mean that the medications are not working and that they require adjustments in dosing or a change in the medications.

Lack of Improvement of Joint Symptoms: One major purpose of seeing the doctor is to get better. The doctor knows this. If a patient with rheumatoid arthritis has seen the doctor and is started on a treatment program and is not showing improvement, but is worsening, notification of the doctor is appropriate. After starting a new treatment program, it sometimes takes time for the medications, physical therapy, etc. to control the inflammation. It is up to the doctor to decide if things are on course.

Fever: A mildly elevated temperature is not unusual in a person with active inflammation from rheumatoid arthritis. However, a true fever (temperature is above 100.4 degrees F or 38 degrees C) is not expected and can represent an infection. Persons with rheumatoid arthritis are at increased risk for infection because of their disease and frequently because of their medications. Many of the medications used to treat rheumatoid disease suppress the immune system of the body that is responsible for defending against infectious microbes. Furthermore, these medications can increase the risk of a more serious infection when a bacterium or virus strikes. It is important for persons with rheumatoid arthritis to notify the doctor as soon as a fever occurs so that infections are treated at the earliest time possible. This can minimize the chances for many serious complications of infections.

Numbness or Tingling: When a joint swells, it can pinch the nerves of sensation that pass next to it. If the swelling irritates the nerve, either because of the inflammation or simply because of pressure, the nerve can send sensations of pain, numbness, and/or tingling to the brain. This is called nerve entrapment. Nerve entrapment most frequently occurs at the wrist (carpal tunnel syndrome) and elbow (ulnar nerve entrapment). It is important to have nerve entrapment treated early for best results. A rare form of nerve disease in patients with rheumatoid arthritis that causes numbness and/or tingling is neuropathy. Neuropathy is nerve damage that in persons with rheumatoid arthritis can result from inflammation of blood vessels (vasculitis). Vasculitis is not common, but it is very dangerous. Therefore, it is important to notify the doctor if numbness and/or tingling occurs.

Rash: Rashes can occur for many reasons in anybody. However, in persons with rheumatoid arthritis, the medications or, rarely, the disease can cause rashes. Medications that commonly cause rashes as side effects include gold (Solganal, Myochrysine), methotrexate (Rheumatrex, Trexall), leflunomide (Arava), and hydroxychloroquine (Plaquenil). A rare, and serious, complication of rheumatoid arthritis is inflammation of blood vessels (vasculitis), which can cause rash that most commonly appears in the finger tips, toes, or legs.

Eye Redness: Redness of the eyes can represent an infection of the eyes, which is more common in persons with rheumatoid arthritis because of dryness of the eyes (Sjogren's syndrome). Redness can also result from blood vessel inflammation (vasculitis), especially when pain is present.

Vision Loss of Red/Green Color Distinction: A rare complication of the commonly used rheumatoid arthritis drug hydroxychloroquine (Plaquenil) is injury to the retina (the light-sensing portion of the back of the eye). The earliest sign of retinal changes from hydroxychloroquine is a decreased ability to distinguish between red and green colors. This occurs because the vision area of the retina that is first affected by the drug normally detects these colors. Persons who are taking hydroxychloroquine (Plaquenil) who lose red/green color distinction should stop the drug and contact their doctor.

Nausea: Nausea is a common problem in patients with rheumatoid arthritis, usually because of the medications that are required to keep the joint inflammation minimized. Medications frequently used to treat rheumatoid arthritis that can cause nausea include non-steroidal antiinflammatory drugs (NSAIDs such as ibuprofen, naproxen, and many others), prednisone and prednisolone, azathioprine (Imuran), and methotrexate (Rheumatrex, Trexall). Nausea is usually not serious, but it is always annoying. Depending on the particular situation, the doctor may have the options of stopping the drug, lowering the dose, and/or adding a medication to treat the nausea.

Vomiting: Vomiting can be caused by the same drugs that cause nausea. Obviously, it is also possible to have a new underlying condition that could cause vomiting. It is most important to notify the doctor about this symptom, not only because of what it could represent, but also because it can lead to dehydration. Dehydration is never good for patients taking arthritis medications as it can increase the chances for side effects of the drugs, such as kidney injury.

Diarrhea: Diarrhea can also lead to dehydration. Diarrhea can be caused by arthritis medications, such as NSAIDs, oral gold, and leflunomide (Arava). Diarrhea is also a common side effect of a medication that is used to protect the stomach while taking NSAIDs, misoprostol (Cytotec). The doctor may discontinue the drug causing the problem, make a dosage adjustment, and/or add a medication to stop the diarrhea.

Constipation: Constipation generally occurs in persons with rheumatoid arthritis because of medications. While constipation can happen with almost any medication, it is most common with the narcotic pain medications, including hydrocodone (Vicodin), propoxyphene (Darvocet), and others. Persons taking these medications should stay well hydrated. If patients with rheumatoid arthritis notice new constipation, the doctor should be notified.

Dark Stools: Dark colored stools can be caused by bleeding from the stomach. Bleeding from the stomach can be caused by inflammation of the stomach lining (gastritis) or ulcers. Gastritis and stomach ulcers are side effects from aspirin or any other NSAID. Persons with dark stools should notify their doctor immediately.

Insomnia: Insomnia is a real hassle. It is not fun and also is not healthy for persons with rheumatoid arthritis, who require good sleep as part of managing their inflammation. Insomnia can occur because painful joints keep persons with rheumatoid arthritis awake. It can also be caused by medications, particularly cortisone medications such as prednisone (Orasone) and prednisolone. There are ways of managing insomnia and the doctor should be notified if it becomes a regular problem.

Dizziness, Lightheadedness, Ringing in the Ears: Dizziness, lightheadedness, or balance problems are dangerous. Common causes include medications, such as aspirin or other NSAIDs, and low red blood counts (anemia). Ringing in the ears (tinnitus) is a frequent side effect of aspirin and NSAIDs. The doctor must be notified should any of these symptoms be noticed.

Headache: Unusual headaches should be reported to the doctor for general purposes and because headache can be a side effect of medications. In particular, headaches can be caused by NSAIDs. Sometimes, the headaches are related to the dosage of the medicine. Lowering the dose can eliminate the headaches while still providing a beneficial effect. All medication changes should be guided by the doctor.

Infection: Persons with rheumatoid arthritis are at increased risk for infection. This risk occurs because the rheumatoid disease is an immune suppressed condition and because many of the medications that are used to treat rheumatoid arthritis can suppress the immune system. Examples of rheumatoid medications that suppress the immune system are methotrexate (Rheumatrex, Trexall), azathioprine (Imuran), infliximab (Remicade), enterecept (Enbrel), cyclosporine (Neoral), and cyclophosphamide (Cytoxan). An infection should be treated with appropriate antibiotics as early as possible before it becomes serious.

Cough or Chest Pain: Chest pain that is caused by arthritis of the chest wall is not an emergency and does not warrant notifying the doctor immediately. However, unexplained chest pain or cough can represent serious underlying disease of the heart or lungs. It should be remembered that persons with rheumatoid arthritis are at increased risk for infection of the breathing passages and lungs. Such infection requires antibiotic treatment. Furthermore, methotrexate (Rheumatrex, Trexall) can cause lung inflammation, the first sign of which is often a persistent cough. Chest pain can also be caused by the reflux of acid from the stomach into the esophagus. This condition can be aggravated by aspirin and other NSAIDs.

NOTE: The warning signs above are not meant to be all inclusive. There are many other symptoms of illness that also are reasons to contact the doctor urgently. For example, vision loss from a stroke or chest pain from a heart attack are reasons to contact a doctor immediately. The symptoms listed above are warning signs that occur more commonly as a result of rheumatoid disease. Persons with rheumatoid arthritis, therefore, should have a heightened alertness for these symptoms. They should also feel free to contact their doctor about any health issues or concerns at any time.

Arthritis Footcare: "It's In The Shoes"

Nude Photo

Many forms of arthritis commonly affect the feet. When they do, walking can be difficult and painful.

Osteoarthritis frequently causes degeneration of the cartilage and bony spurs at the base of the big toe. This is what leads to bunions. Wider shoes may be necessary. High-heeled and pointed shoes should be avoided since they can put unnecessary pressure at the point of the bunion. Degeneration of the arch of the foot can lead to spur formation on the top of the foot. This can put pressure on adjacent nerves of sensation, which can cause burning of the foot and toes. When this discomfort occurs, patients should avoid tying the shoe tightly or wear a shoe that does not bind at the point of the spur.

Rheumatoid arthritis causes inflammation of the joints at the ball of the foot, which loosens their ligaments and can cause the bone to push against the skin of the bottom of the foot. This can lead to tender calluses and ulcerations at the ball of the foot, which may even require surgical repair. A bar of leather attached to the bottom of the shoe behind the arch of the foot can help by displacing pressure from the ball to the middle of the foot. Further rheumatoid deformity can cause the toes to cock up, which can lead to abrasion of the tops of the toes.
Box-toed shoes can be extremely comfortable for persons with these deformities. Lumps of soft tissues, called nodules, can form on the sides of the foot, heel, or on the toes. Nodules can ulcerate from abrasion of shoes. Sometimes, slits cut into the shoe at the point of the nodules can help to relieve painful pressure. Furthermore, non-tie style laces are now available, thus making it easier for persons with rheumatoid arthritis to fasten the shoes.

Gout can cause hard deposits of uric acid crystals to form a lump at the inner side of the base of the big toe. Depending on the size of the deposit, there can be abrasion and even ulceration from the shoe. Wider style shoes can be helpful.

Occasionally, doctors will examine the shoes that a patient has worn to find evidence of deformity (for instance, a shoe leaning to one side or another), wear, and alignment. The independent shoe exam is like a history book of the use of the foot over recent months. It can sometimes be used to help define not only causes of foot pains, but also ankle, knee, or hip pains.

In general, running shoes are frequently an advantage because of their lightweight. Proper shoes can provide welcome relief and often improved function for patients with foot damage from arthritis. When picking out a shoe, ALWAYS try on several pair and walk around in them before purchasing. The salesperson will understand that you are interested in both function and comfort.

Great-fitting shoes are worth investing time and effort. Be kind to your feet and they will get you where you want to go!

Happy Trails

Arthritis and Exercise, How Do I Start?

Nude Photo

People with arthritis should discuss exercise options with their doctors and other health care providers. Most doctors recommend exercise for their patients. Many people with arthritis begin with easy, range-of-motion exercises and low-impact aerobics. People with arthritis can participate in a variety of, but not all, sports and exercise programs. The doctor will know which, if any, sports are off-limits.

The doctor may have suggestions about how to get started or may refer the patient to a physical therapist. It is best to find a physical therapist who has experience working with people who have arthritis. The therapist will design an appropriate home exercise program and teach clients about pain-relief methods, proper body mechanics (placement of the body for a given task, such as lifting a heavy box), joint protection, and conserving energy.

Step Up to Exercise: How To Get Started!

* Discuss exercise plans with your doctor.


* Start with supervision from a physical therapist or qualified athletic trainer.


* Apply heat to sore joints (optional; many people with arthritis start their exercise program this way).


* Stretch and warm up with range-of-motion exercises.


* Start strengthening exercises slowly with small weights (a 1- or 2-pound weight can make a big difference).


* Progress slowly.


* Use cold packs after exercising (optional; many people with arthritis complete their exercise routine this way).


* Add aerobic exercise.


* Consider appropriate recreational exercise (after doing range-of-motion, strengthening, and aerobic exercise). Fewer injuries to joints affected by arthritis occur during recreational exercise if it is preceded by range-of-motion, strengthening, and aerobic exercise that gets your body in the best condition possible.


* Ease off if joints become painful, inflamed, or red, and work with your doctor to find the cause and eliminate it.


* Choose the exercise program you enjoy most and make it a habit.

How Much Exercise Is Too Much?

Most experts agree that if exercise causes pain that lasts for more than 1 hour, it is too strenuous. People with arthritis should work with their physical therapist or doctor to adjust their exercise program when they notice any of the following signs of strenuous exercise:

* Unusual or persistent fatigue
* Increased weakness
* Decreased range of motion
* Increased joint swelling
* Continuing pain (pain that lasts more than 1 hour after exercising)

The above information has been provided with the kind permission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (http://www.niams.nih.gov/hi/topics/arthritis/arthexfs.htm).

Arthritis Diet Claims: Fact or Fiction

Nude Photo

Pain from arthritis might lead you to try anything to relieve it, including a change in diet or taking supplements. Make sure you know what works first.

By presidential proclamation, we're living in the National Bone and Joint Decade, 2002-2011, and that means we should be seeing a surge in research into causes and treatments of arthritis and other diseases.

Meanwhile, many people with osteoarthritis (OA) and rheumatoid arthritis (RA) seek relief by buying the latest book or nutritional supplement claiming to relieve or cure arthritis, or they take advice from a neighbor who swore that eating gin-soaked raisins eased her symptoms.

How do you navigate this gray area of unregulated therapies to know if what you're doing can help or harm? WebMD talked with two experts who provided insight into the claims made for arthritis diets and supplements. Hayes Wilson, MD, is a rheumatologist in Atlanta and medical adviser for the Arthritis Foundation. Christine Gerbstadt, RD, MD, practices in Pittsburgh and is a spokeswoman for the American Dietetic Association.

Here's a guide to help you sort fact from fiction:

Diets

* Eliminate nightshades. One of the most common diet claims is that eliminating nightshades, which include potatoes, tomatoes, eggplants, and most peppers, relieves arthritis. This diet probably isn't harmful, but there are no studies to support it.


* Alkaline diet. The alkaline diet presumes both OA and RA are caused by too much acid. Among the foods it excludes are sugar, coffee, red meat, most grains, nuts, and citrus fruits. It's meant to be followed for just one month. It may be that people feel better because they lose weight, reducing stress on joints, which eases pain. This diet eliminates most vitamin C sources. There are no studies to support it.


* Dong diet. This restrictive diet relies heavily on vegetables, except tomatoes, and eliminates many of the same foods as the alkaline diet. There's no evidence it affects arthritis.


* Vegetarian diet. Some people report improvement in symptoms, but evidence is mixed. One small study of people with RA showed improvement in four weeks, and follow-up studies of those who stayed on the diet showed continued improvement after one and two years.


* Switching fats. One of the known correlations between food and arthritis is that omega-6 fatty acids increase inflammation, and omega-3 fatty acids reduce it. Limit intake of meat and poultry, and increase your intake of cold-water fish, such as sardines, mackerel, trout, and salmon. For salad dressings and cooking, substitute olive, canola, and flaxseed oils for corn, safflower, and sunflower oils.


* Gin-soaked raisins. Lots of people claim it works, but experts say there's no evidence. Grapes and raisins do contain anti-inflammatory compounds, but not in amounts that would be therapeutic. The gin might dull pain, but drinking to excess sabotages health benefits of nutrients and vitamins, and introduces a whole new set of problems.


* Green tea. Drinking three to four cups of green tea a day could help people with RA. Studies funded by the Arthritis Foundation showed that giving the polyphenolic compounds in green tea to mice significantly decreased the incidence and severity of RA. Human studies have not yet confirmed the results.

Nutritional Supplements

* ASU (avocado-soybean unsaponifiable). French studies of ASU, derived from avocado and soybean oils, show it can relieve OA pain, stimulate cartilage repair, and lower a patient's need for nonsteroidal anti-inflammatory drugs (NSAIDs) to control pain. Jason Theodosakis, MD, author of The Arthritis Cure and champion of glucosamine chondroitin, believes ASU will have a major impact on treatment of OA. Sold in France by prescription under the name Piascledine 300, it's available in the U.S. without a prescription.


* Black currant oil. See GLA.


* Borage oil. See GLA.


* Boron. Population studies show that people who have high-boron diets have a very low incidence of arthritis, and there's evidence that people with OA and RA can benefit. The best sources of boron are fresh fruits and vegetables and, depending on where you live, drinking water.


* Bovine cartilage. Taken from the windpipe and trachea of cows, it's supposed to act as an anti-inflammatory agent in the treatment of OA and RA. A few animal and laboratory studies are promising, but there are no human studies to support claims. Researchers also think it may promote regrowth of cartilage.


* Bromelain. This substance found in pineapple is supposed to relieve pain and swelling in OA and RA and improve mobility. There are no studies that show it's effective by itself, but one study of a bromelain supplement containing the enzymes rutin and trypsin relieved pain and improved function in 73 people with knee OA. The effect was similar to taking an NSAID.


* CMO. It's touted as an "arthritis cure," but there's no human clinical evidence to support it.


* Chondroitin sulfate. Used for many years in Europe to relieve OA pain, it's been shown to stop joint degeneration, improve function, and ease pain. One study followed patients with OA in finger joints for three years, and showed fewer patients developed further cartilage damage. It can take two months or more to realize the effects of chondroitin.


* DMSO. Once widely used to relieve joint and tissue inflammation, it fell out of favor when animal studies showed high doses damaged the lens of the eye. Don't use it without consulting your doctor.


* Evening primrose oil. See GLA.


* Fish oil. Studies show it relieves the pain of RA.


* Flaxseed. There are many good nutritional reasons to add it to your diet, but studies of its effect on arthritis have shown mixed results. Its anti-inflammatory properties work best if other vegetable-based oils are restricted.


* GLA. Gamma linolenic acid (GLA) is an omega-6 fatty acid the body uses to make anti-inflammatory agents, unlike other omega-6 fatty acids that actually increase inflammation. It's found in evening primrose oil, black currant oil, and borage oil supplements. Several studies show it relieves the stiffness and pain of RA. In one study, some patients were able to quit taking NSAIDs.


* Ginger. It's known to have painkilling and anti-inflammatory agents. Ginger is believed to reduce joint pain and inflammation in people with OA and RA, and protect the stomach from gastrointestinal effects of NSAIDs. A clinical study showed ginger reduced knee OA pain.


* Glucosamine. As glucosamine hydrochloride or glucosamine sulfate, this supplement relieves symptoms for many, but not all, people with OA. It helps the body build and repair cartilage. In a double-blind study, glucosamine sulfate was as effective in relieving symptoms in patients with knee OA as ibuprofen and had fewer side effects. It takes about two months to realize the effectiveness of this supplement. Although it's derived from crab, lobster, or shrimp shells, it seems not to cause problems for people with shellfish allergies.


* Glucosamine chondroitin. Many OA patients get relief by taking glucosamine and chondroitin together, but it's not known whether the combination is more effective than taking them alone. That's the subject of a National Institutes of Health (NIH) study called GAIT (glucosamine/chondroitin arthritis intervention trial) now under way. The research shows how effective the supplements are in terms of improving functional ability and reducing pain in people with knee OA. Results are expected to be published in 2005.


* MSM. It's widely touted for relief of pain and inflammation. Its safety and effectiveness have yet to be determined.


* SAM-e. Many European studies over the last 20 years show SAM-e is as effective as anti-inflammatory painkillers in treating OA but with fewer side effects. It works in conjunction with vitamin B-12, B-6, and folate. Claims that SAM-e repairs and rebuilds cartilage lack evidence, as studies have been done only in the lab and in animals.


* Shark cartilage. Ground-up cartilage from Pacific Ocean sharks is supposed to relieve the inflammation and pain of arthritis. Animal and lab studies are promising, but there are no human studies to support claims. Researchers also think it may promote regrowth of cartilage.


* Stinging nettle. Taken orally or applied to the skin, stinging nettle is supposed to reduce the pain and inflammation of OA. Some studies show that patients can lower their dosages of NSAIDs by taking stinging nettle in extract form. Two small studies showed stinging nettle applied topically reduced pain for people with hip OA and thumb joint pain.


* Turmeric. This supplement is used in traditional Chinese and Indian Aruyvedic medicine to relieve pain, stiffness, and inflammation of OA and RA. A small study that combined turmeric, boswellia, and zinc showed decreased pain in OA. Two studies using a combination of turmeric, boswellia, ginger, and aswangandha relieved pain and inflammation in RA. Its effectiveness alone is unknown.


* Wild yam. Although it contains natural anti-inflammatory steroids, they're not in a form the body can use.

Use Caution

Experimenting with foods and supplements is not without risks. "I know people get desperate enough to try anything, but I would not feel comfortable eliminating whole groups of food," says Gerbstadt. "Before you eliminate any foods or modify your diet, check with a nutritionist."

"The best advice is to eat a healthy, well balanced diet and stay close to your ideal body weight so affected joints have less extra weight to carry around," says Wilson. "Also get plenty of rest and exercise and decrease stress."

Be aware that many supplements interfere with or enhance effects of medications you're already taking. For example, a number of supplements increase the effects of blood-thinning medication. Check with your doctor.

Published Aug. 6, 2004.

SOURCES: Archives of Internal Medicine, July 14, 2003. The Arthritis Foundation's Guide to Alternative Therapies, by Judith Horstman. Hayes Wilson, MD, medical advisor, Arthritis Foundation. Christine Gerbstadt, RD, MD, spokeswoman, American Dietetic Association. Arthritis Foundation. Web site of Jason Theodosakis , MD.

© 2005 WebMD Inc. All rights reserved.

Alternative Ways to Easing Arthritis Pain

Nude Photo

Experts look at the pros and cons of alternative arthritis therapies.

Alternative therapies for arthritis range from A (acupuncture) to Z (zinc sulfate), with much in between -- from copper bracelets to magnets to glucosamine to yoga, to name just a few. But do alternative therapies for arthritis really work?

Many arthritis sufferers are looking into alternative therapies in an effort to find relief from the pain, stiffness, stress, anxiety, and depression that accompany the disease. Indeed, the Arthritis Foundation reports that two-thirds of those suffering from the disease have tried alternative therapies.

Some Work, Many Don't

A survey conducted for Arthritis Today by Leigh Callahan, PhD, reported that the favorite alternative therapies of the 790 arthritis sufferers who responded to the survey included everything from prayer and meditation to glucosamine and magnets. Callahn is associate director of the Thurston Arthritis Research Center at the University of North Carolina, Chapel Hill.

Of the 2,146 physicians who responded to the survey, the alternative therapies most recommended were capsaicin, relaxation, biofeedback, meditation, journal writing, yoga, spirituality, tai chi, acupuncture, and glucosamine.

And some of these alternative treatments really work, say leading arthritis specialists, and even have scientific evidence behind them (although most doctors admit that more research is needed). On the other hand, many more of the alternative treatments don't work or need more studies to support anecdotal claims.

Battling Arthritis With Movement

Deborah Litman, MD, a clinical assistant professor in the division of rheumatology at the Georgetown University School of Medicine, is a strong proponent of exercise (though it's not listed as an alternative treatment per se) in the treatment of arthritis.

Biking, for example, she explains, strengthens the quadriceps muscle above the knee; the stronger the muscle, the more likely you are to see an improvement in your symptoms.

"Impact-loading" activity, on the other hand, such as jogging or high-impact aerobics, is not recommended, but more gentle exercise, such as swimming or water aerobics, is.

The mind-body practice of yoga may also help arthritis sufferers.

Though there are few studies that look at the effects of yoga on arthritis per se, a 1994 study published in the British Journal of Rheumatology did find that people with rheumatoid arthritis who participated in a yoga program over a three-month period had greater handgrip strength compared with those who did not practice yoga.

The same year, another study published in the Journal of Rheumatology reported that arthritis sufferers who practiced yoga showed a significant improvement in pain, tenderness, and finger range of motion for osteoarthritis of the hands.

Sticking It to Arthritis Pain

Acupuncture is another possibility; it is a therapy that has been studied extensively. As far as we know, says Litman, it doesn't change the course of the illness. But it can be helpful in managing pain and reducing stress associated with living with the chronic condition.

In 1980, the World Health Organization endorsed acupuncture for the treatment of some 40 ailments, including both osteoarthritis and rheumatoid arthritis.

In 1997, an NIH panel also concluded that acupuncture was not only helpful for postoperative pain and nausea, but also could help in the treatment of fibromyalgia and other musculoskeletal conditions, and without the side effects of anti-inflammatory drugs.

The University of Maryland School of Medicine recently completed a four-year NIH-funded study, the largest ever undertaken, to determine how well acupuncture works. The results, published in December 2004 in the Annals of Internal Medicine, found that traditional Chinese acupuncture significantly reduces pain and improves function for patients with knee osteoarthritis who have moderate or more severe pain despite taking pain medication.

Larry Altshuler, MD, is a board-certified internist in Oklahoma City who practices both conventional and alternative medicine. He uses acupuncture on his arthritis patients and says he was "pleasantly surprised" when his patients reported they were getting relief from their pain. "Most of my patients have had beneficial results from acupuncture," says Altshuler.

Helpful, Healthy Supplements?

Glucosamine and chondroitin are nutritional supplements that are also being studied for their effectiveness in treating arthritis.

Jason Theodosakis, MD, says that "first-line therapies" for the treatment of arthritis should always be improving biomechanics, injury prevention, weight control, and low-impact exercise. Theodosakis is an assistant clinical professor at the University of Arizona College of Medicine; he serves on the oversight committee for a $16 million NIH trial on glucosamine and chondroitin.

"But there is also enough scientific evidence -- 42 human clinical trials to date -- to recommend the use of glucosamine and chondroitin," says Theodosakis, also the author of The Arthritis Cure.

An article published in 2001 in the medical journal Lancet, for example, reported the results of a three-year study that followed 212 arthritis sufferers. The survey participants were divided into two groups, with one group given 1,500 milligrams of glucosamine daily for three years; the other group was given a daily placebo for three years.

The group given the glucosamine showed little or no deterioration in joints, while the group given the placebo showed the joint deterioration expected of arthritis sufferers.

After further follow-up, a recent study published in Osteoarthritis and Cartilage, found that those in the glucosamine group had 74% fewer knee replacements.

Erin Arnold, MD, recommends not only glucosamine sulfate for her patients (1,500 milligrams a day, taken in two to three doses a day), but also 400-800 international units of vitamin D. Arnold is a rheumatologist at the Illinois Bone and Joint Institute in Chicago.

"Lower levels of vitamin D in the body are associated with higher levels of pain," she says. She also recommends 1,000 milligrams a day of vitamin C, 200 milligrams of omega-3 fatty acid twice a day, and 2 cups of green tea every day for its anti-inflammatory effects.

One nutritional supplement that has been receiving much attention lately is MSM (methyl sulfonyl methane).

MSM, which can be found in fresh fruits and vegetables, milk, fish, and grains, is destroyed when foods are processed; if your diet is made up of a lot of processed foods, you may be low in MSM levels.

Several animal studies have seemed promising, including one published in 1985 in the journal Immunopathology that reported that MSM eased rheumatoid-arthritis-like effects in mice. In a recent small study of 50 men and women conducted by Leslie Axelrod, ND, of the Southwest College of Naturopathic Medicine in Tempe, Ariz., patients who received MSM reported 12% less pain and 14% more knee function than those who were given a placebo.

Choose Wisely

Because the quality of herbs and supplements can vary, even some of these treatments might not work, cautions Tod Cooperman, MD, president of ConsumerLab.com.

ConsumerLab.com reviewed supplement products touted for their pain-relieving benefits. It found that one product, claiming to contain 500 milligrams per serving of "chondroitin sulfate complex" actually contained less than 90 milligrams of chondroitin sulfate -- only 18% of the 500 milligrams.

"Fortunately, most products contain what they claim," says Cooperman. "But consumers should choose their supplements wisely. If a product is not working, it may be the product itself that is flawed, and not the approach."

Useless, Dangerous Remedies?

There are a number of other alternative remedies that arthritis sufferers try.

Many of those -- such as copper bracelets or magnets -- may not have much, if any, scientific evidence to back them up or disprove them. Indeed, Kerry Ludlam, a spokeswoman for the Arthritis Foundation, reports that there is a lack of research both for and against the usefulness of alternative therapies.

"There's a void of information," she says. Since many of the alternative therapies cited for the relief of arthritis are considered harmless (other than perhaps to your pocketbook), many doctors say that if you want to try them, go ahead.

Other therapies, however, can be dangerous.

Bee venom could cause a potentially fatal reaction in those allergic to stinging insects. And even glucosamine, generally safe for most people, could be dangerous for people allergic to shellfish. (Shellfish-free glucosamine is now available.) For these reasons, it's important to check with your doctor first before trying any alternative treatment.

It's also important to note that herbs and supplements may have unknown and potentially dangerous interactions with medication. If you're taking medication, it's best to check with your doctor before trying any supplements.

Getting Started

Though more and more doctors are themselves investigating the benefits of alternative therapies and have no objections if their patients try some, most of them still suggest first following the medical guidelines for the treatment of osteoarthritis released by the American College of Rheumatology and the American Pain Society.

Begin with treatments such as exercise and weight loss, the guidelines advise, in combination with over-the-counter acetaminophen as directed by your personal physician.

"Try the simplest and cheapest regimen first," says Litman. "That should be your first line of defense."

Published Oct. 3, 2005.

SOURCES: Deborah Litman, MD, clinical assistant professor, Georgetown University. Larry Altshuler, MD, board-certified internist. Jason Theodosakis, MD, assistant clinical professor, University of Arizona College of Medicine. Erin Arnold, MD, Illinois Bone and Joint Institute. University of Maryland Medical Center web site: "Osteoarthritis Sufferers Seek Complementary Care." Arthritis Foundation: "Guide to Alternative Therapies." Vignon, E. Arthritis & Rheumatism, September 2003; vol 48: p S77. Reginster, J. Lancet, January 2001; vol 357: pp 251-256. WebMD Medical News: "Modest Arthritis Benefit Seen from MSM." Pavelka, J. Osteoarthritis and Cartilage, October 2004; vol 12: p S74. Tod Cooperman, MD, president Consumerlab.com. Kerry Ludlam, spokeswoman, Arthritis Foundation National Office.